Boston Scientific (MEX:BSX) Stock Based Compensation: MXN5,637 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BSX Boston Scientific Corp MEX:BSX
83 GF Score
Price MXN780.00
GF Value MXN1,851.88
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Stock Based Compensation?

Boston Scientific MEX:BSX +3.17% 83 Stock Based Compensation is MXN5,637 Mil as of Mar. 2026. GuruFocus rates MEX:BSX with a GF Score™ of 83/100 and a GF Value™ of MXN1,851.88 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Boston Scientific's Stock Based Compensation for the three months ended in Mar. 2026 was MXN1,497 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was MXN5,637 Mil.

Boston Scientific Stock Based Compensation Related Terms

Boston Scientific Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Stock Based Compensation Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,979.72 4,289.12 3,955.00 5,547.62 5,383.70

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,513.91 1,412.19 1,449.19 1,278.41 1,496.71
MEX:BSX
83GF Score
Boston Scientific Corp MEX:BSX
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,637 Mil.

What does a Stock Based Compensation of MXN5,637 Mil mean?
Boston Scientific (MEX:BSX) has a Stock Based Compensation of MXN5,637 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Boston Scientific and its competitors.
Is Boston Scientific's Stock Based Compensation too high?
Boston Scientific's current Stock Based Compensation is MXN5,637 Mil. Overall, Boston Scientific has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Stock Based Compensation compare to EW and GEHC?
Boston Scientific's Stock Based Compensation of MXN5,637 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Boston Scientific and its competitors. Boston Scientific's current Stock Based Compensation is MXN5,637 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,851.88, compared to a current price of MXN780.00 — trading 57.9% below its estimated fair value. The current Stock Based Compensation is MXN5,637 Mil. Boston Scientific's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Stock Based Compensation is MXN5,637 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN780.00 is trading 57.9% below its estimated GF Value™ of MXN1,851.88. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Stock Based Compensation: MXN5,637 Mil
  • GF Value™: MXN1,851.88 vs. price of MXN780.00 (57.9% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
83GF Score

Get the complete analysis for MEX:BSX

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN780.00
Price
MXN1,851.88
GF Value